Revenue

A strategic investment in cybersecurity firm ShorePoint reveals how private capital is becoming a critical force multiplier in securing federal agencies.

Nova Era Labs promises to revolutionize AI education with virtual labs. But in a market of giants, can it deliver on its bold claims of workforce readiness?

A key regulatory filing reveals First Trust Advisors' major stake in NCC Group, fueling speculation as the UK cybersecurity firm weighs a potential sale.

Emergency rooms are failing kids in crisis. See how one hospital is partnering with community experts to build a faster, more effective path to healing.

The ADA’s new standards push for tech from day one and holistic care, but can the system deliver this innovative future to every patient?

The U.S. Army awards a major contract for the P550 UAS, a modular, AI-driven drone set to revolutionize battlefield intelligence and soldier safety.

75% of employees say pet health impacts their work stress. Discover why pet benefits are no longer a perk, but a key strategy for productivity and talent retention.

A South Korean biotech's novel antibody, now named rapaprutug, could shift the paradigm for pulmonary arterial hypertension by targeting its root causes.

The biotech is advancing a promising myelofibrosis therapy while developing a next-gen 'super drug,' a dual strategy signaling significant growth.

A hedge fund's subtle move in Unite Group offers a rare glimpse into the high-stakes strategy behind the UK's student housing consolidation boom.

An Amazon e-commerce firm is making a high-stakes leap into homeland security. Can new leadership and disruptive AI tech transform the company's future?

For the fifth year, GCM Grosvenor is a top workplace. We explore how their people-first strategy is a key asset in the competitive world of finance.

A new report reveals a shocking gap: as autonomous AI agents flood enterprises, only 21% have visibility, creating a massive, unaddressed security risk.

After key legal setbacks, Pason Systems settles its IP litigation. We decode what this confidential agreement means for investors and future innovation.

Sana Biotech’s new data shows it can edit stem cells directly in the body, a potential game-changer for blood disorders and a challenge to current therapies.

PHOTRON's takeover of AOS Technologies signals a major shift in the high-speed camera market, with deep implications for automotive safety and defense.

Priority Technology's chairman wants to take the firm private at a premium, but a special committee and vocal investors are now weighing the offer.

As the humanoid robotics market soars towards $7.7B, one firm is recruiting top talent to find the next big winner. What does this move signal to investors?

As the aging U.S. grid strains under explosive demand, industrial leaders are turning to microgrids for energy independence and financial stability.

As AI-driven deepfakes surge, a 5-year-old film reveals why media literacy is the most critical, yet overlooked, infrastructure for our smart cities.